Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma (1994)

Peer-Reviewed Study · Iarussi D, Auricchio U, Agretto A, Murano A, Giuliano M, Casale F, Indolfi P, Iacono A · 1994

Iarussi D et al., 1994: Controlled study in 20 children with ALL or non-Hodgkin lymphoma: 10 received coenzyme Q10 alongside anthracyclines, 10 did not. Left-ventricular fractional shortening fell significantly in both groups but less in the CoQ10 group, and septal thickening fell only in the untreated group.

These data demonstrate a protective effect of CoQ on cardiac function during therapy with ANT.

Abstract

Iarussi D et al., 1994: Controlled study in 20 children with ALL or non-Hodgkin lymphoma: 10 received coenzyme Q10 alongside anthracyclines, 10 did not. Left-ventricular fractional shortening fell significantly in both groups but less in the CoQ10 group, and septal thickening fell only in the untreated group. Not described as randomised in the record ('control study'); 10 patients per arm, single centre (Naples). CoQ10 dose and duration are not stated in the abstract; full text is paywalled (Mol Aspects Med 1994;15 Suppl:s207-12). No funding or conflict-of-interest statement appears in the PubMed record. Comparator: concurrent controls receiving anthracyclines without CoQ10 (not placebo). Study type: controlled study.